• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微粒体酰基葡萄糖醛酸化:对不稳定葡萄糖醛酸苷的酶动力学研究

Microsomal acyl glucuronidation: enzyme-kinetic studies with labile glucuronides.

作者信息

Spahn-Langguth H, Benet L Z

机构信息

Department of Pharmacology, Johann-Wolfgang-Goethe University, Frankfurt a/M., Germany.

出版信息

Pharmacology. 1993 May;46(5):268-73. doi: 10.1159/000139054.

DOI:10.1159/000139054
PMID:8488171
Abstract

Because of the labile nature of acyl glucuronides under physiologic conditions, metabolic rates of formation calculated using traditional methods may be confounded by concomitant rates of degradation. True metabolic formation rates may be approximated by stabilization of the metabolic product or by purifying the metabolite and calculating its degradation rate under similar conditions to that utilized in the formation experiments. This latter degradation rate is used to correct the apparent formation parameter in the absence of inhibitors. The advantages and limitations of each approach are reviewed employing studies to characterize rates of acyl glucuronidation for nonsteroidal antiinflammatory drugs.

摘要

由于酰基葡萄糖醛酸在生理条件下的不稳定性,使用传统方法计算的形成代谢率可能会受到同时发生的降解率的干扰。真正的代谢形成率可以通过稳定代谢产物或通过纯化代谢物并在与形成实验中使用的条件相似的条件下计算其降解率来近似。在没有抑制剂的情况下,后一种降解率用于校正表观形成参数。通过研究非甾体抗炎药的酰基葡萄糖醛酸化率来综述每种方法的优缺点。

相似文献

1
Microsomal acyl glucuronidation: enzyme-kinetic studies with labile glucuronides.微粒体酰基葡萄糖醛酸化:对不稳定葡萄糖醛酸苷的酶动力学研究
Pharmacology. 1993 May;46(5):268-73. doi: 10.1159/000139054.
2
Contribution of the human kidney to the metabolic clearance of drugs.
Ann Pharmacother. 1992 Nov;26(11):1421-8. doi: 10.1177/106002809202601116.
3
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.人肝、肾和小肠微粒体对霉酚酸的葡萄糖醛酸结合和葡萄糖苷结合反应
Br J Pharmacol. 2001 Mar;132(5):1027-34. doi: 10.1038/sj.bjp.0703898.
4
Effect of selective phase II enzyme inducers on glucuronidation of benoxaprofen in rats.选择性II期酶诱导剂对大鼠中贝诺洛芬葡萄糖醛酸化的影响。
Drug Metab Dispos. 1999 Dec;27(12):1423-8.
5
N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.抗癫痫药物瑞替加滨的N-葡萄糖醛酸化:来自人类志愿者、异源表达的人类尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)、人肝脏、肾脏以及II型克里格勒-纳贾尔综合征患者肝脏微粒体膜研究的结果
Metabolism. 2006 Jun;55(6):711-21. doi: 10.1016/j.metabol.2006.01.006.
6
Characterization of the in vitro glucuronidation of flurbiprofen enantiomers.氟比洛芬对映体的体外葡萄糖醛酸化特征
Drug Metab Dispos. 1995 Mar;23(3):343-8.
7
Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.依达拉奉在人肝微粒体和肾微粒体中的葡萄糖醛酸化:双相动力学及 UGT1A9 为主要的 UDP-葡萄糖醛酸基转移酶同工酶的鉴定。
Drug Metab Dispos. 2012 Apr;40(4):734-41. doi: 10.1124/dmd.111.043356. Epub 2012 Jan 11.
8
N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.N-葡萄糖醛酸化反应。I. 大鼠、犬、猴和人肝微粒体中选定的血管紧张素II受体拮抗剂的四氮唑N-葡萄糖醛酸化。
Drug Metab Dispos. 1993 Sep-Oct;21(5):792-9.
9
Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.鉴定人 UDP-葡糖醛酸基转移酶参与lorcaserin 的 N-碳酰胺葡糖醛酸化。
Drug Metab Dispos. 2012 Apr;40(4):772-8. doi: 10.1124/dmd.111.043448. Epub 2012 Jan 18.
10
UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.尿苷二磷酸葡萄糖醛酸基转移酶1A1是负责依托泊苷在人肝脏和肠道微粒体中进行葡萄糖醛酸化的主要酶:依托泊苷酚类和醇类葡萄糖醛酸苷的结构表征及酶动力学估算
Drug Metab Dispos. 2007 Mar;35(3):371-80. doi: 10.1124/dmd.106.012732. Epub 2006 Dec 6.

引用本文的文献

1
Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.
Clin Pharmacokinet. 1992 Oct;23(4):292-310. doi: 10.2165/00003088-199223040-00005.